Anson Funds logo

Anson Funds

North America, Texas, United States, Dallas

Description

Anson Funds is an investment management firm that invests in companies engaging in publicly-traded equity and debt securities.

Investor Profile

Anson Funds has made 5 investments, with 4 in the past 12 months and 80% as lead.

Stage Focus

  • Post Ipo Equity (60%)
  • Post Ipo Debt (40%)

Country Focus

  • United States (80%)
  • Canada (20%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Therapeutics
  • Artificial Intelligence (Ai)
  • Smart Building
  • Software
  • Sustainability
  • Advertising
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Anson Funds frequently co-invest with?

Bridger Holdings
North America, California, United States, Palo Alto
Co-Investments: 1
RXR Realty
North America, New York, United States, New York
Co-Investments: 1
NBT Capital Management
North America, New York, United States, Johnson City
Co-Investments: 1
Cantor Fitzgerald
North America, New York, United States, New York
Co-Investments: 1
AC
North America, Texas, United States, San Antonio
Co-Investments: 1

What are some of recent deals done by Anson Funds?

InterRent REIT

Ottawa, Ontario, Canada

InterRent REIT is a growth-oriented real estate investment trust.

Real Estate
Post Ipo EquityMar 10, 2025
Amount Raised: $90,108,387
NRx Pharmaceuticals

Wilmington, Delaware, United States

NRx Pharmaceuticals is a pharmaceutical company developing therapeutics for the treatment of central nervous system disorders.

BiopharmaBiotechnologyHealth CarePharmaceuticalTherapeutics
Post Ipo EquityJan 28, 2025
Amount Raised: $3,500,000
Lionsgate

Los Angeles, California, United States

Lionsgate is an entertainment company involved in film, television, and digital content production and distribution.

AdvertisingContentDigital MediaMedia and EntertainmentPublishing
Post Ipo EquityDec 10, 2024
NRx Pharmaceuticals

Wilmington, Delaware, United States

NRx Pharmaceuticals is a pharmaceutical company developing therapeutics for the treatment of central nervous system disorders.

BiopharmaBiotechnologyHealth CarePharmaceuticalTherapeutics
Post Ipo DebtAug 13, 2024
Amount Raised: $16,000,000
View

Milpitas, California, United States

View is a smart building technology company that produces smart windows that adjusts in response to external conditions.

Artificial Intelligence (AI)Smart BuildingSoftwareSustainability
Post Ipo DebtOct 16, 2023
Amount Raised: $50,000,000